Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 8 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced TumorsStatus unknownNCT04979390Phase 1
• Study of SHR-1701 Plus BP102 in Subjects With Selected Solid TumorsStatus unknownNCT04974957Phase 2
• A Study of SHR-1707 in Healthy Young Adult and Elderly SubjectsCompletedNCT04973189Phase 1
• A Drug-drug Interaction Study of SHR6390 on Healthy Chinese VolunteersCompletedNCT04973020Phase 1
• Extension Study of Hetrombopag in Severe Aplastic AnemiaActive, not recruitingNCT04961710Phase 3
• To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic ArthritisActive, not recruitingNCT04957550Phase 3
• A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With GoutCompletedNCT04956432Phase 3
• A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal CandidiasisStatus unknownNCT04956419Phase 3
• A Trial of SHR1701 Plus Chemotherapy in Patients With Gastric or Gastroesophageal CancerActive, not recruitingNCT04950322Phase 3
• SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's LymphomaStatus unknownNCT04948788Phase 2
• To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy SubjectsCompletedNCT04945616Phase 1
• A Trial of SHR-A1904 in Patients With Advanced Pancreatic CancerStatus unknownNCT04928625Phase 1
• A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus NephritisStatus unknownNCT04924296Phase 2
• Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical CancerActive, not recruitingNCT04906993Phase 3
• A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild AsthmaCompletedNCT04905602Phase 1
• Relative Bioavailability Study of SHR3680Status unknownNCT04903158Phase 1
• A Trial of HR19042 Capsule in Healthy Chinese SubjectsCompletedNCT04887532Phase 1
• Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With HypercholesterolemiaCompletedNCT04885218Phase 3
• A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung CancerStatus unknownNCT04884009Phase 2
• A Study of SHR-A1904 in Patients With Advanced Solid CancerActive, not recruitingNCT04877717Phase 1
• Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT04875169Phase 3
• A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Castration Resistant Prostate CancerCompletedNCT04869488Phase 2
• Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General AnesthesiaCompletedNCT04867343Phase 2
• A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy SubjectsStatus unknownNCT04862884Phase 1
• Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate CancerCompletedNCT04862091Phase 2
• A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRCTerminatedNCT04856787Phase 2/3
• Trial of SHR-1701 Plus BP102 in Subjects With Selected Solid TumorsCompletedNCT04856774Phase 1/2
• A Trial of SHR-1703 in Healthy SubjectsTerminatedNCT04855591Phase 1
• A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower AbdominalCompletedNCT04852003Phase 3
• Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy SubjectsCompletedNCT04850651Phase 1
• Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single Arm, Open, Self-control)CompletedNCT04850638Phase 1
• Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ StageCompletedNCT04849000Phase 3
• SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical ResearchCompletedNCT04844125Phase 3
• A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid TumorsTerminatedNCT04842630Phase 1
• Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Receptor Positive,Human Epidermal Receptor 2 NegativeActive, not recruitingNCT04842617Phase 3
• Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing SpondylitisCompletedNCT04840485Phase 2/3
• Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque PsoriasisStatus unknownNCT04839016Phase 3
• A Trial of SHR2285 in Healthy SubjectsCompletedNCT04829305Phase 1
• A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung CancerActive, not recruitingNCT04818333Phase 1/2
• A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.CompletedNCT04812860Phase 2
• HR021618 in Moderate to Severe Pain After Abdominal SurgeryCompletedNCT04811053Phase 2
• A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy SubjectsCompletedNCT04802811Phase 1
• A Trial of SHR-1905 in Healthy SubjectsCompletedNCT04800263Phase 1
• The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without DiabetesStatus unknownNCT04799327Phase 2
• A Study of Irinotecan Liposome in Advanced Pancreatic CancerCompletedNCT04796948Phase 1
• A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic SurgeryStatus unknownNCT04794738Phase 2/3
• Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects.Status unknownNCT04775615Phase 1
• Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With VitiligoTerminatedNCT04774809Phase 2/3
• A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy SubjectsCompletedNCT04772365Phase 1
• A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery.CompletedNCT04766463Phase 3
• A Trial of SHR-1707 in Healthy Young Adult and Elderly SubjectsCompletedNCT04745104Phase 1
• Hetrombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaCompletedNCT04737850Phase 3
• A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian CancerCompletedNCT04718740Phase 1
• Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic DermatitisActive, not recruitingNCT04717310Phase 2/3
• Study on the Bioavailability of SHR0302 in Healthy SubjectsCompletedNCT04712838Phase 1
• A Trial of SHR8735 in Healthy SubjectsCompletedNCT04701216Phase 1
• A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLCWithdrawnNCT04699968Phase 2
• A Trial of HR021618 in Postsurgical Pain ManagementStatus unknownNCT04699175Phase 2
• Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver FunctionCompletedNCT04694365Phase 1
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerActive, not recruitingNCT04691804Phase 3
• Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine FormulationsCompletedNCT04688008Phase 1
• A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical CancerCompletedNCT04680988Phase 2
• Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A InducerStatus unknownNCT04680091Phase 1
• A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid TumorsStatus unknownNCT04679038Phase 1/2
• The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and OmeprazoleCompletedNCT04676035Phase 1
• An Open Label Study of the Effects of SHR1459 in NMOSDs PatientsCompletedNCT04670770Phase 2
• Study to Investigate Relative Bioavailability of Different Formulations of SHR6390 in Healthy SubjectsCompletedNCT04667156Phase 1
• Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin MonotherapyStatus unknownNCT04667143Phase 3
• Drug-drug Interaction of SHR3680 With Repaglinide and BupropionStatus unknownNCT04664725Phase 1
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral AntidiabeticsCompletedNCT04663282Phase 2
• SHR-1701 in Patients With Recurrent/Metastatic ScchnStatus unknownNCT04650633Phase 2
• Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin)CompletedNCT04649723Phase 1
• A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationActive, not recruitingNCT04639180Phase 3
• An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy ParticipantsStatus unknownNCT04631575Phase 1
• An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy ParticipantsStatus unknownNCT04631549Phase 1
• A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult SubjectsCompletedNCT04627129Phase 1
• A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic CancerCompletedNCT04624217Phase 1/2
• Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin HydrochlorideCompletedNCT04621669Phase 1
• Study on the Food Effects of Oral SHR4640 Tablets in Healthy VolunteersStatus unknownNCT04620408Phase 1
• A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.TerminatedNCT04619433Phase 3
• Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male VolunteersCompletedNCT04616742Phase 1
• A Food Effect Study of FMTN on Healthy Chinese Adult SubjectsCompletedNCT04616716Phase 1
• A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)CompletedNCT04613674Phase 3
• A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPCStatus unknownNCT04603833Phase 2
• Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy VolunteersStatus unknownNCT04586803Phase 1
• A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLCActive, not recruitingNCT04580498Phase 2
• A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult SubjectsCompletedNCT04577885Phase 1
• A Trial of HRS4800 Tables in Healthy Male SubjectsCompletedNCT04573036Phase 1
• A Trial of SHR1258 in Patients With Biliary Tract CancerWithdrawnNCT04571710Phase 2
• A Trial of SHR-1819 in Healthy SubjectsCompletedNCT04561128Phase 1
• The PK/PD Study of SHR7280 Tablets in Healthy Subjects.CompletedNCT04554043Phase 1
• A Trial of HR18034 in Inguinal Hernia RepairStatus unknownNCT04551924Phase 1
• The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.Status unknownNCT04546815
• A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy SubjectsStatus unknownNCT04527484Phase 1
• Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult SubjectsCompletedNCT04521192Phase 1
• A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer PatientsCompletedNCT04517357Phase 2
• A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing TumorsCompletedNCT04513223Phase 1
• A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on FamitinibCompletedNCT04494659Phase 1
• A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing SpondylitisCompletedNCT04481139Phase 2/3
• A Trial of SHR-1703 in Healthy AdultsCompletedNCT04480762Phase 1

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas